L. Bartos
33 Papers
L. Bartos is an academic researcher. The author has contributed to research in topics: Medicine & Translocator protein. The author has an hindex of 4, co-authored 17 publications.
Chat about Author
Papers
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models
Bettina van Lengerich,Lihong Zhan,Dan Xia,Darren K.W. Chan,David A Joy,Joshua I. Park,David Tatarakis,Meredith E. K. Calvert,Selina Hummel,Steve Lianoglou,Michelle E. Pizzo,Rachel Prorok,Elliot R. Thomsen,L. Bartos,Philipp Beumers,Anja Capell,Sonnet S. Davis,Lis de Weerd,Jason C. Dugas,Joseph N. Duque,Timothy K. Earr,Kapil Gadkar,Tina Giese,Audrey Gill,Johannes Gnörich,Connie Ha,Malavika Kannuswamy,Do Jin Kim,Sebastian T Kunte,L. Kunze,Diana Lac,Kendra J. Lechtenberg,Amy Wing-Sze Leung,Chun-Chi Liang,Isabel Lopez,Paul V. McQuade,Anuja Modi,Vanessa O Torres,Hoang Nguyen,Ida Pesämaa,Nicholas E. Propson,Marvin Reich,Yaneth Robles-Colmenares,Kai Schlepckow,L. Slemann,Hilda Solanoy,Jung H. Suh,Robert G. Thorne,Chandler Vieira,Karin Wind-Mark,Ken Xiong,Y. Joy Yu Zuchero,Dolo Diaz,Mark S. Dennis,Fen Huang,Kimberly Scearce-Levie,Ryan J. Watts,Christian Haass,Joseph W. Lewcock,Gilbert Di Paolo,Matthias Brendel,Pascal E. Sanchez,Kathryn M. Monroe +62 more
TL;DR: A high affinity human TREM2-activating antibody engineered with a monovalent transferrin receptor (TfR) binding site, termed antibody transport vehicle (ATV), was used to facilitate blood-brain barrier transcytosis as mentioned in this paper .
Distinct molecular profiles of skull bone marrow in health and neurological disorders
Z. I. Kolabas,L. B. Kuemmerle,Robert Perneczky,Benjamin Förstera,Selin Ulukaya,Mayar Ali,Saketh Kapoor,L. Bartos,Maren Büttner,Ozum S. Caliskan,Zhouyi Rong,Hongcheng Mai,Luciano Höher,Denise Jeridi,Muge Molbay,Igor Khalin,I.K. Deligiannis,Moritz Negwer,Kenny Roberts,Alba Simats,O Carofiglio,Mihail Ivilinov Todorov,Izabela Horvath,Furkan Ozturk,Selina Hummel,Gloria Biechele,A.V Zatcepin,Marcus Unterrainer,Johannes Gnörich,Jay Roodselaar,Joshua Shrouder,Pardis Khosravani,Benjamin Tast,Lisa Richter,Laura Díaz-Marugán,Doris Kaltenecker,Laurin Lux,Ying Chen,Shan Zhao,Boris-Stephan Rauchmann,Michael Sterr,I. Kunze,Karen Stanic,Vanessa W. Y. Kan,S. Besson-Girard,Sabrina Katzdobler,Carla Palleis,Julia Schädler,Johannes C. Paetzold,Sabine Liebscher,Anja E. Hauser,Ozgun Gokce,Heiko Lickert,Hanno Steinke,Corinne Benakis,Christian Braun,Celia P. Martinez-Jimenez,Katharina Buerger,Nathalie L. Albert,Günter U. Höglinger,Johannes Levin,Christian Haass,Anna Kopczak,Martin Dichgans,Joachim Havla,Tania Kümpfel,Martin Kerschensteiner,Martina Schifferer,Mikael Simons,Arthur Liesz,Natalie Krahmer,Omer Ali Bayraktar,Nicolai Franzmeier,Nikolaus Plesnila,Suheda Erener,Victor G. Puelles,Claire Delbridge,Harsharan S. Bhatia,Farida Hellal,Markus Elsner,Ingo Bechmann,Benjamin Ondruschka,Matthias Brendel,Fabian J. Theis,Ali Erturk +84 more
TL;DR: The mouse skull has the most distinct transcriptomic profile compared with other bones in states of health and injury, characterized by a late-stage neutrophil phenotype, and the unique molecular profile and anatomical and functional connections of the skull show its potential as a site for diagnosing, monitoring, and treating brain diseases.
60
Depletion and activation of microglia impact metabolic connectivity of the mouse brain
Johannes Gnörich,Anika Reifschneider,Karin Wind,A.V Zatcepin,Sebastian T Kunte,Philipp Beumers,L. Bartos,T. Wiedemann,M Grosch,Xianyuan Xiang,Maryam K. Fard,Francois Ruch,Georg Werner,Mara Koehler,L. Slemann,Selina Hummel,Nils Briel,Tanja Blume,Yuan Shi,Gloria Biechele,Leonie Beyer,Florian Eckenweber,Maximilian Scheifele,Peter Bartenstein,Nathalie L. Albert,Jochen Herms,Sabina Tahirovic,Christian Haass,Anja Capell,Sibylle Ziegler,Matthias Brendel +30 more
TL;DR: In this article , the impact of microglial activity and microglia FDG uptake on metabolic connectivity was investigated, and it was shown that increased metabolic connectivity is associated with increased microglion FDG allocation.
TSPO PET signal using [18F]GE180 is associated with survival in recurrent gliomas
S. Quach,Adrien Holzgreve,Lena Kaiser,Marcus Unterrainer,Franziska J. Dekorsy,Debie Nelwan,L. Bartos,S V Kirchleitner,Jonathan Weller,Lorraine Weidner,Maximilian Niyazi,Viktoria Ruf,Jochen Herms,Sophia Stöcklein,Christian H. Wetzel,Markus J. Riemenschneider,Louisa V Baumgarten,Niklas Thon,Matthias Brendel,Rainer Rupprecht,Peter Bartenstein,Jörg C. Tonn,Nathalie L. Albert +22 more
TL;DR: In this paper , the authors correlated the TSPO positron emission tomography (PET) signal using [18F]GE180 in a large cohort of recurrent glioma patients with their clinical outcome.
Combination of pre-treatment dynamic [18F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma
Zhicong Li,Adrien Holzgreve,L. Unterrainer,Viktoria Ruf,S. Quach,L. Bartos,Bogdana Suchorska,Maximilian Niyazi,Vera Wenter,Jochen Herms,Peter Bartenstein,Jörg C. Tonn,Marcus Unterrainer,Nathalie L. Albert,Lena Kaiser +14 more
TL;DR: In this paper , a prediction model which incorporates clinical parameters and radiomic features extracted from static as well as dynamic [18 F]FET PET for the survival stratification in patients with newly diagnosed IDH-wildtype glioblastoma was built and evaluated.